Medical Care

Global Recombinant Antibody Market Research Report 2025

The global market for Recombinant Antibody was valued at US$ 197 million in the year 2024 and is projected to reach a revised size of US$ 215 million by 2031, growing at a CAGR of 1.3% during the forecast period.
Recombinant antibodies are antibodies produced through genetic engineering techniques, often using mammalian cells or other expression systems. They are used in research, diagnostics, and therapeutics.
The market for recombinant antibodies is growing due to their versatility in applications, including cancer therapy, autoimmune disease treatment, and targeted drug delivery. Advances in antibody engineering and production technologies are contributing to this trend.
This report aims to provide a comprehensive presentation of the global market for Recombinant Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Antibody.
The Recombinant Antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abnova
Medix Biochemica
GE Healthcare
SinoBiological
Bioventix
Segment by Type
Chimeric Antibody
Humanized Antibody
Full Human Antibody
Single Chain Antibody
Bispecific Antibody
Segment by Application
Hospital
Scientific Research
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Recombinant Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Antibody Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Chimeric Antibody
1.2.3 Humanized Antibody
1.2.4 Full Human Antibody
1.2.5 Single Chain Antibody
1.2.6 Bispecific Antibody
1.3 Market by Application
1.3.1 Global Recombinant Antibody Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Scientific Research
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Recombinant Antibody Market Perspective (2020-2031)
2.2 Global Recombinant Antibody Growth Trends by Region
2.2.1 Global Recombinant Antibody Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Recombinant Antibody Historic Market Size by Region (2020-2025)
2.2.3 Recombinant Antibody Forecasted Market Size by Region (2026-2031)
2.3 Recombinant Antibody Market Dynamics
2.3.1 Recombinant Antibody Industry Trends
2.3.2 Recombinant Antibody Market Drivers
2.3.3 Recombinant Antibody Market Challenges
2.3.4 Recombinant Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant Antibody Players by Revenue
3.1.1 Global Top Recombinant Antibody Players by Revenue (2020-2025)
3.1.2 Global Recombinant Antibody Revenue Market Share by Players (2020-2025)
3.2 Global Recombinant Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Recombinant Antibody Revenue
3.4 Global Recombinant Antibody Market Concentration Ratio
3.4.1 Global Recombinant Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Antibody Revenue in 2024
3.5 Global Key Players of Recombinant Antibody Head office and Area Served
3.6 Global Key Players of Recombinant Antibody, Product and Application
3.7 Global Key Players of Recombinant Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant Antibody Breakdown Data by Type
4.1 Global Recombinant Antibody Historic Market Size by Type (2020-2025)
4.2 Global Recombinant Antibody Forecasted Market Size by Type (2026-2031)
5 Recombinant Antibody Breakdown Data by Application
5.1 Global Recombinant Antibody Historic Market Size by Application (2020-2025)
5.2 Global Recombinant Antibody Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Recombinant Antibody Market Size (2020-2031)
6.2 North America Recombinant Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Recombinant Antibody Market Size by Country (2020-2025)
6.4 North America Recombinant Antibody Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Recombinant Antibody Market Size (2020-2031)
7.2 Europe Recombinant Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Recombinant Antibody Market Size by Country (2020-2025)
7.4 Europe Recombinant Antibody Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Recombinant Antibody Market Size (2020-2031)
8.2 Asia-Pacific Recombinant Antibody Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Recombinant Antibody Market Size by Region (2020-2025)
8.4 Asia-Pacific Recombinant Antibody Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Recombinant Antibody Market Size (2020-2031)
9.2 Latin America Recombinant Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Recombinant Antibody Market Size by Country (2020-2025)
9.4 Latin America Recombinant Antibody Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant Antibody Market Size (2020-2031)
10.2 Middle East & Africa Recombinant Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Recombinant Antibody Market Size by Country (2020-2025)
10.4 Middle East & Africa Recombinant Antibody Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abnova
11.1.1 Abnova Company Details
11.1.2 Abnova Business Overview
11.1.3 Abnova Recombinant Antibody Introduction
11.1.4 Abnova Revenue in Recombinant Antibody Business (2020-2025)
11.1.5 Abnova Recent Development
11.2 Medix Biochemica
11.2.1 Medix Biochemica Company Details
11.2.2 Medix Biochemica Business Overview
11.2.3 Medix Biochemica Recombinant Antibody Introduction
11.2.4 Medix Biochemica Revenue in Recombinant Antibody Business (2020-2025)
11.2.5 Medix Biochemica Recent Development
11.3 GE Healthcare
11.3.1 GE Healthcare Company Details
11.3.2 GE Healthcare Business Overview
11.3.3 GE Healthcare Recombinant Antibody Introduction
11.3.4 GE Healthcare Revenue in Recombinant Antibody Business (2020-2025)
11.3.5 GE Healthcare Recent Development
11.4 SinoBiological
11.4.1 SinoBiological Company Details
11.4.2 SinoBiological Business Overview
11.4.3 SinoBiological Recombinant Antibody Introduction
11.4.4 SinoBiological Revenue in Recombinant Antibody Business (2020-2025)
11.4.5 SinoBiological Recent Development
11.5 Bioventix
11.5.1 Bioventix Company Details
11.5.2 Bioventix Business Overview
11.5.3 Bioventix Recombinant Antibody Introduction
11.5.4 Bioventix Revenue in Recombinant Antibody Business (2020-2025)
11.5.5 Bioventix Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Recombinant Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Chimeric Antibody
Table 3. Key Players of Humanized Antibody
Table 4. Key Players of Full Human Antibody
Table 5. Key Players of Single Chain Antibody
Table 6. Key Players of Bispecific Antibody
Table 7. Global Recombinant Antibody Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Recombinant Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Recombinant Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Recombinant Antibody Market Share by Region (2020-2025)
Table 11. Global Recombinant Antibody Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Recombinant Antibody Market Share by Region (2026-2031)
Table 13. Recombinant Antibody Market Trends
Table 14. Recombinant Antibody Market Drivers
Table 15. Recombinant Antibody Market Challenges
Table 16. Recombinant Antibody Market Restraints
Table 17. Global Recombinant Antibody Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Recombinant Antibody Market Share by Players (2020-2025)
Table 19. Global Top Recombinant Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Antibody as of 2024)
Table 20. Ranking of Global Top Recombinant Antibody Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Recombinant Antibody Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Recombinant Antibody, Headquarters and Area Served
Table 23. Global Key Players of Recombinant Antibody, Product and Application
Table 24. Global Key Players of Recombinant Antibody, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Recombinant Antibody Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Recombinant Antibody Revenue Market Share by Type (2020-2025)
Table 28. Global Recombinant Antibody Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Recombinant Antibody Revenue Market Share by Type (2026-2031)
Table 30. Global Recombinant Antibody Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Recombinant Antibody Revenue Market Share by Application (2020-2025)
Table 32. Global Recombinant Antibody Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Recombinant Antibody Revenue Market Share by Application (2026-2031)
Table 34. North America Recombinant Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Recombinant Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Recombinant Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Recombinant Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Recombinant Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Recombinant Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Recombinant Antibody Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Recombinant Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Recombinant Antibody Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Recombinant Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Recombinant Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Recombinant Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Recombinant Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Recombinant Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Recombinant Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 49. Abnova Company Details
Table 50. Abnova Business Overview
Table 51. Abnova Recombinant Antibody Product
Table 52. Abnova Revenue in Recombinant Antibody Business (2020-2025) & (US$ Million)
Table 53. Abnova Recent Development
Table 54. Medix Biochemica Company Details
Table 55. Medix Biochemica Business Overview
Table 56. Medix Biochemica Recombinant Antibody Product
Table 57. Medix Biochemica Revenue in Recombinant Antibody Business (2020-2025) & (US$ Million)
Table 58. Medix Biochemica Recent Development
Table 59. GE Healthcare Company Details
Table 60. GE Healthcare Business Overview
Table 61. GE Healthcare Recombinant Antibody Product
Table 62. GE Healthcare Revenue in Recombinant Antibody Business (2020-2025) & (US$ Million)
Table 63. GE Healthcare Recent Development
Table 64. SinoBiological Company Details
Table 65. SinoBiological Business Overview
Table 66. SinoBiological Recombinant Antibody Product
Table 67. SinoBiological Revenue in Recombinant Antibody Business (2020-2025) & (US$ Million)
Table 68. SinoBiological Recent Development
Table 69. Bioventix Company Details
Table 70. Bioventix Business Overview
Table 71. Bioventix Recombinant Antibody Product
Table 72. Bioventix Revenue in Recombinant Antibody Business (2020-2025) & (US$ Million)
Table 73. Bioventix Recent Development
Table 74. Research Programs/Design for This Report
Table 75. Key Data Information from Secondary Sources
Table 76. Key Data Information from Primary Sources
Table 77. Authors List of This Report


List of Figures
Figure 1. Recombinant Antibody Picture
Figure 2. Global Recombinant Antibody Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Recombinant Antibody Market Share by Type: 2024 VS 2031
Figure 4. Chimeric Antibody Features
Figure 5. Humanized Antibody Features
Figure 6. Full Human Antibody Features
Figure 7. Single Chain Antibody Features
Figure 8. Bispecific Antibody Features
Figure 9. Global Recombinant Antibody Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Recombinant Antibody Market Share by Application: 2024 VS 2031
Figure 11. Hospital Case Studies
Figure 12. Scientific Research Case Studies
Figure 13. Others Case Studies
Figure 14. Recombinant Antibody Report Years Considered
Figure 15. Global Recombinant Antibody Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Recombinant Antibody Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Recombinant Antibody Market Share by Region: 2024 VS 2031
Figure 18. Global Recombinant Antibody Market Share by Players in 2024
Figure 19. Global Top Recombinant Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Antibody as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Recombinant Antibody Revenue in 2024
Figure 21. North America Recombinant Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Recombinant Antibody Market Share by Country (2020-2031)
Figure 23. United States Recombinant Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Recombinant Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Recombinant Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Recombinant Antibody Market Share by Country (2020-2031)
Figure 27. Germany Recombinant Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Recombinant Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Recombinant Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Recombinant Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Recombinant Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Recombinant Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Recombinant Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Recombinant Antibody Market Share by Region (2020-2031)
Figure 35. China Recombinant Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Recombinant Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Recombinant Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Recombinant Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Recombinant Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Recombinant Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Recombinant Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Recombinant Antibody Market Share by Country (2020-2031)
Figure 43. Mexico Recombinant Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Recombinant Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Recombinant Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Recombinant Antibody Market Share by Country (2020-2031)
Figure 47. Turkey Recombinant Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Recombinant Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Recombinant Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Abnova Revenue Growth Rate in Recombinant Antibody Business (2020-2025)
Figure 51. Medix Biochemica Revenue Growth Rate in Recombinant Antibody Business (2020-2025)
Figure 52. GE Healthcare Revenue Growth Rate in Recombinant Antibody Business (2020-2025)
Figure 53. SinoBiological Revenue Growth Rate in Recombinant Antibody Business (2020-2025)
Figure 54. Bioventix Revenue Growth Rate in Recombinant Antibody Business (2020-2025)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies